DD vs SER · P/E 127, rev $12.39B vs rev $56.0K
Dupont De Nemours Inc (DD) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. SER currently screens at market cap $29.7M.
Not investment advice. Open the DD and SER stock pages for the full models.
Not investment advice.